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Regenerative medicine requires new ways to assemble and manipulate cells for 
fabrication of tissue-like constructs. Here we report a novel approach for cell
surface engineering of human cells using polymer-stabilized magnetic nano-
particles (MNPs). Cationic polyelectrolyte-coated MNPs are directly deposited 
onto cellular membranes, producing a mesoporous semi-permeable layer and 
rendering cells magnetically responsive. Deposition of MNPs can be completed
within minutes, under cell-friendly conditions (room temperature and physiologic
media). Microscopy (TEM, SEM, AFM, and enhanced dark-field imaging) 
revealed the intercalation of nanoparticles into the cellular microvilli network.
A detailed viability investigation was performed and suggested that MNPs do
not inhibit membrane integrity, enzymatic activity, adhesion, proliferation, or 
cytoskeleton formation, and do not induce apoptosis in either cancer or primary
cells. Finally, magnetically functionalized cells were employed to fabricate viable




Magnetically driven assembly of human cells into 
artificial multicellular clusters mimicking human 
tissues is regarded as a powerful tool in regenerative 
medicine [1, 2].  
Magnetically facilitated tissue engineering employs 
the introduction of magnetic nanoparticles (MNPs) 
into or onto live cells as an effective means for remote 
magnetic field-based control of spatial deposition of 
cells and fabrication of layered tissue-like structures 
[3]. Over the past decade, researchers worldwide 
have focused on the elaboration of novel techniques 
for the effective magnetic functionalization of mam-
malian cells and their subsequent use for controllable 
cell assembly. Several reports demonstrate the successful 
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implementation of MNPs-modified cells in fabrication 
of artificial constructs imitating vascular tissue [4], 
skeletal muscle tissues [5], and keratinocyte sheets [6]. 
Magnetic functionalization of cells was also employed 
in fabrication of cellular spheroids [7], which are 
regarded as three-dimensional building blocks in tissue 
engineering and a prospective tool in pharmaceutical 
applications (i.e., drug screening) [8] and tumor studies 
[9]. MNPs-modified cells were also employed for 
fabrication of aortic valve mimics using a magnetic 
levitation procedure [10]. Overall, artificial addition 
of magnetic functionality in cells allows for effective 
spatial manipulation using relatively simple and 
accessible magnetic fields, which dramatically improves 
control over geometry, size distribution, and cell 
distribution within multicellular constructs, highlighting 
magnetic methods in tissue engineering as a promising 
direction in modern regenerative medicine. 
Rendering cells with magnetic functionality requires 
labeling human cells with MNPs. To date, most publi-
shed techniques have employed passive internalization 
of MNPs via endocytosis, which allows for effective 
magnetic modification of cells [11–13]. However, uptake 
of MNPs by cells entails several major drawbacks, 
such as (1) a lengthy internalization process, requiring 
up to 72 h of co-incubation of MNPs with cells [14, 15] 
and (2) potential toxic effects of early-stage cytoplasm- 
internalized nanoparticles [16]. Early reports demon-
strate the use of magnetic cationic liposomes (MCLs) 
fabricated using mixtures of 10-nm magnetite nano-
particles and lipids [5]. Use of positively charged 
MCLs as delivery vehicles improves the accumulation 
of MNPs in target cells via electrostatic interactions 
with negatively charged cellular membranes [4]. 
Magnetic nanoparticles are internalized into the 
cytoplasm via co-incubation of MCLs with cells for 
several hours. However, experimental approaches 
based on cell-internalized magnetic nanoparticles have 
raised concerns regarding possible long-term toxic 
effects. To minimize the potential toxic effects of MNPs, 
several recent studies have suggested using MNPs 
isolated from magnetotactic bacteria [17], which are 
believed to be less toxic than chemically synthesized 
MNPs, fabrication of magnetoferritin nanoparticles, 
or construction of Janus magnetic cellular spheroids 
by concentrating nanoparticles in certain regions of 
spheroids, thus reducing MNPs–cell interactions [8]. 
Although effective, these approaches are rather complex 
and require time-consuming manipulation of cells or 
sophisticated methods of nanoparticle preparation. 
To avoid these obstacles, we recently suggested  
an alternative approach based on the deposition    
of poly(allylamine)-stabilized (PAH) MNPs on cell 
membranes [18]. Polymer-stabilized cationic magnetic 
nanoparticles self-assembled on cell membranes within 
several minutes and did not penetrate the cytoplasm 
of HeLa cells. Polyelectrolyte-stabilized MNPs readily 
assemble on cells, without use of any supramolecular 
linkers, such as streptavidin-biotin chemistry [19]. 
Subsequently, we employed PAH-MNPs-modified 
human cells for magnetically facilitated fabrication of 
lung tissue-mimicking multicellular clusters [20]. In 
this paper, we report the detailed study of cell surface 
engineering of human cells with polyelectrolyte- 
stabilized MNPs and demonstrate the magnetically 
facilitated fabrication of artificial multicellular clusters 
using MNPs-functionalized cells. We found that PAH- 
MNPs-functionalization of cells does not affect the 
viability of cells, and that surface-engineered magnetic 
cells remain metabolically active, colonize available 
substrates, and gradually remove the nanoparticles 
from their surfaces. We investigated the distribution 
of MNPs on cell surfaces at early and late stages of 
cell growth. Cell surface engineering with PAH-MNPs 
allowed us to fabricate layered tissue-like clusters and 
multicellular spheroids, demonstrating the potential 
of our approach for tissue engineering. 
2 Experimental 
2.1 Chemicals and materials 
All chemicals used in this study were purchased 
from Sigma-Aldrich unless otherwise noted, were of 
analytical grade, and were used as received. Ultrapure 
Milli-Q water was used throughout. 
2.2 Synthesis and characterization of MNPs 
MNPs were prepared as follows: 2.0 mL of 1 M FeCl3 
and 0.5 mL of 2 M FeCl2 aqueous solutions were mixed 
and stirred vigorously, then 50 mL of 0.5 M aqueous 
NaOH was added dropwise while stirring. The dark  
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iron oxide precipitate was then separated using a 
magnet and washed extensively with water until the 
pH was neutral. To stabilize the MNPs with cationic 
PAH polymer, 1 mL of as-prepared nanoparticles was 
mixed with 10 mL of 10 mg·mL–1 aqueous PAH, and the 
mixture was sonicated for 10 min, incubated for 12 h, 
and then separated by centrifugation and washed with 
Milli-Q water. The hydrodynamic size and iron oxide 
core size of MNPs were determined using dynamic 
light scattering and atomic force microscopy (AFM). 
2.3 Cell lines and cultivation 
Primary human skin fibroblasts (HSF) were isolated 
from an adult skin biopsy sample and cultivated in 
minimal Eagle’s medium Alfa (αMEM) supplemented 
with 0.2 mM L-glutamine, 100 U/ml penicillin, 100 μg/ml 
streptomycin, and 10% heat-inactivated bovine serum 
(PAA Laboratories). Fibroblasts between the fourth 
and eleventh passages were used in the experiments. 
Human lung carcinoma epithelial cells (A549) were 
obtained from the American Type Culture Collection 
(ATCC, Rockville, Maryland, USA). A549 cells were 
cultivated in Dulbecco’s modified minimal Eagle’s 
medium (DMEM) with L-glutamine supplemented 
with 100 U/ml penicillin, 100 μg/ml streptomycin, and 
10% fetal bovine serum (PAA Laboratories). Cells were 
routinely passaged after they approached 90%–95% 
confluence with 0.05% trypsin–EDTA solution (Gibco) 
and split at a ratio 1:10–1:20. For magnetization experi-
ments, cells at 70%–90% confluence were split into a 
flask (75 cm2) at a ratio of 1:3 the day before use. Cells 
were detached from the surface of the flask using 0.05% 
trypsin–EDTA during 5 min of incubation followed 
by centrifugation and washing with DPBS. 
2.4 Functionalization of cells with MNPs 
A suspension of MNPs (0.05 mg/ml) in 0.15 M NaCl 
was filtered through a 0.22-μm Millipore syringe filter 
to eliminate larger aggregates and to sterilize the 
suspension. The nanoparticle suspension was added 
to a 106-cell pellet in a tube from which the supernatant 
had previously been removed. After 3 min of incubation 
with gentle vortexing, the cells were separated from 
the remaining MNPs by centrifugation (1,000 rpm) 
and washed twice with DPBS. 
2.5 Physiological activity tests 
2.5.1 Apoptosis induction 
The ability of MNPs to induce apoptosis was tested 
with ethidium bromide/acridin orange staining 
according to the manufacturer’s protocol. Fluorescence 
microscopy was used to estimate cell viability in the 
stained samples. The enzymatic activity and percentage 
of apoptotic cells were evaluated using flow cytometry 
with Merocyanin 540 (MC540)/fluorescein diacetate 
(FDA) staining after 0, 12, and 24 h of incubation with 
MNPs. A BD FACSCanto (Biosciences) instrument was 
used. Data were obtained using the FACSDiva software. 
2.5.2 MTT assay 
The cytotoxicity of PAH-MNPs was determined using 
an 3(4,5-dimethylthiazoyl-2-yl) 2,5 diphenyltetrazolium 
bromide (MTT) assay. MTT is reduced by mitochondrial 
dehydrogenase in viable cells, producing insoluble 
purple formazan. MNPs-functionalized and intact 
A549 and HSF cells were plated in 96-well plates 
(7,000 cells per well) and allowed to attach overnight 
in a humidified atmosphere with 5% CO2 at 37 °C. The 
MTT stock solution (5 mg/ml) was prepared fresh in 
PBS from MTT powder, and 10 μl of this solution was 
added to each 100 μl of medium using a multichannel 
pipette; plates were incubated at 37 °C for 4 h. The 
medium was removed by inverting the plate on blotting 
tissue, and 200 μl of dimethylsufoxide (DMSO) was 
added to each well to solubilize the formazan. The 
absorbance was measured using a microplate reader 
(Multiskan FC, Thermo Fisher Scientific, USA) at 
540 nm. 
2.5.3 Neutral red uptake assay  
The neutral red (NR) working solution (0.033%) was 
prepared in appropriate culture medium immediately 
prior to performing the test and filtered through a 
0.22-μm syringe filter. MNPs-functionalized and intact 
A549 and HSF cells were plated into 96-well culture 
plates (10,000 cells per well) and incubated in a 
humidified atmosphere with 5% CO2 at 37 °C for 24 h. 
The medium was replaced with 200 μL of NR working 
solution, and plates were incubated in a CO2-incubator 
for 3 h. Next, the cells were fixated with 10% formalde-
hyde and 10% CaCl2 for 1 min at room temperature. 
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The dye was extracted from cells using 200 μL of 
solvent solution (1% glacial acetic acid in 50% ethanol, 
prepared immediately before use). The optical density 
of the NR solution was measured at 540 nm and 
690 nm (reference value) using a microplate reader 
after shaking for 15 min at room temperature. 
2.5.4 Resazurin reduction assay  
MNPs-functionalized and intact A549 and HSF cells 
were seeded in 96-well plates (7,000 cells per well) 
and cultivated in a humidified atmosphere with   
5% CO2 at 37 °C for 24 h. The culture medium was 
removed and replaced with 200 μl of resazurin solution 
(0.01 mg·ml–1) in an appropriate culture medium, and 
plates were incubated overnight. The absorbance was 
measured at 570 nm using a microplate reader. The 
rate of resazurin reduction is directly proportional to 
the number of viable cells. 
2.5.5 Acridine orange and ethidium bromide staining 
Acridine orange/ethidium bromide (AO/EtBr) staining 
combined with fluorescent microscopy was used to 
distinguish early apoptotic from necrotic cells. AO 
intercalates into DNA, producing green fluorescence, 
and the nuclei of viable cells appear green. Early 
apoptotic cells show condensed or fragmented green 
nuclei. EtBr can be taken up only by non-viable cells 
with damaged membranes; dead cells show a bright 
orange nucleus. MNPs-functionalized and intact 
A549 and HSF cells were plated into 96-well plates 
(10,000 cells per well) and incubated in a humidified 
atmosphere with 5% CO2 at 37 °C for 24 h. Then cells 
were stained with 10 μl of AO/EtBr solution (1% and 
0.5%, respectively) for 5 min and visualized using a 
fluorescence microscope to estimate the number of 
apoptotic, necrotic, and viable cells. 
2.6 Scaffold-free tissue engineering using magnetic 
cells 
2.6.1 Layered multicellular clusters 
We employed NdFeB cylindrical rod-shaped magnets 
(E-magnets, UK) that were 3 mm in diameter, 4 mm 
long, with a pull strength of 0.27 kg. 
First layer: MNPs-coated HSF cells (3,000 cells per 
well) were seeded in 6-well culture plates, then 3 mm 
NdFeB cylindrical magnets were deposited below 
each culture well. The cells were incubated for 24 h, 
and then the wells were flushed with DPBS to remove 
non-attached cells.  
Second layer: The procedure was repeated using 
MNPs-coated A549 cells (5,000 cells per well). After 
incubating the cells for 24 h, the round multicellular 
clusters were collected using a permanent magnet or 
a pipette tip and further characterized. 
2.6.2 Fabrication of magnetic spheroids (culture of one cell 
type) 
A549 cells were coated with PAH-MNPs, as described 
above. For spheroid formation, 15-μl drops of culture 
medium containing 2,000 magnetically functionalized 
cells were placed on the inner side of a culture dish. 
Then the cap was inverted and the culture dish was 
covered with 1.5 ml of DPBS. Cells were cultured in 
hanging drops in a humidified atmosphere with 5% 
CO2 at 37 °C. 
2.6.3 Fabrication of hybrid magnetic spheroids (culture of 
two cell types) 
Hybrid multicellular spheroids were formed using 
two types of magnetically functionalized cells (A549 
and HeLa cells) by mixing cell suspensions (~500 cells 
of each type for 1 spheroid). Cells of both cell types 
were fluorescently tagged using dialkylcarbocyanines 
(Vibrant®, Invitrogen): DID (fluorescence excitation 
(Ex) and emission (Em) maxima at 644 nm and 665 nm, 
respectively) was used for labeling of A549 cells; 
HeLa cells were labeled using Dil (fluorescence Ex 
and Em maxima at 549 nm and 565 nm, respectively). 
After fabrication, samples were imaged using confocal 
microscopy. 
2.6.4 F-actin staining and imaging 
Spheroids grown on sterile coverslips were washed 
twice with PBS. Then the spheroids were fixated using 
4% paraformaldehyde in PBS for 10 min, followed by 
washing in PBS. Cells were permeabilized with 1% 
Triton X-100 in PBS for 3–5 min followed by washing 
in PBS. Then blocking solution (1% BSA in PBS) was 
applied for 30 min to prevent nonspecific binding. 
One unit of Alexa Fluor 488® phalloidin conjugate 
(Life Technologies) in 200 μl was applied to each 
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sample followed by washing twice in PBS. Then   
the coverslips were dried and embedded into Eukitt 
mounting media. Samples were examined using 
confocal microscopy. 
2.7 Characterization techniques 
Hydrodynamic diameters and ζ-potentials of nano-
particles and cells were measured using a Malvern 
Zetasizer Nano ZS instrument. Optical and fluorescence 
microscopy images were obtained using a Carl Zeiss 
Axio Imager microscope equipped with an AxioCam 
HRC CCD camera. Cell culture wells were examined 
using a Zeiss Observer Z1 inverted microscope. TEM 
images of the thin-sectioned MNPs-functionalized 
cells were obtained using a JEOL 1200 EX microscope 
operating at 80 kV. The cells were fixed with 2.5% 
glutaraldehyde, gradually dehydrated using ethanol, 
embedded into EPON resin, and then thin sections 
were cut using an LKB ultramicrotome equipped 
with a diamond knife and mounted on copper grids. 
The samples were stained with 2% aqueous uranyl 
acetate and lead citrate. SEM images were obtained 
using a Merlin Carl Zeiss instrument. Cells were 
dehydrated and placed on SEM stubs. Samples were 
sputter-coated with Au (60%) and Pd (40%) alloy 
using a Q150R (Quorum Technologies) instrument. 
Images were obtained at 3 × 10–4 Pa working pressure 
and 15 kV accelerating voltage using the InLens 
detection mode. AFM images of MNPs and MNPs- 
coated cells were obtained using a Dimension FastScan 
instrument (Bruker) with ScanAsyst-Air probes working 
at a scan rate of 1.7 Hz. The images were processed 
using NanoScope Analysis software (Bruker). Confocal 
microscopy images were collected using a Carl Zeiss 
LSM 780 microscope, and images were processed using 
ZEN software. 
3 Results and discussion 
3.1 Magnetic nanoparticle synthesis and  
characterization 
Functionalization of human cells with magnetic 
nanoparticles for tissue engineering requires the use 
of highly biocompatible nanoparticles, since toxic 
effects may severely damage the cells. We synthesized 
PAH-coated iron oxide nanoparticles, which have 
previously been applied for magnetic functionalization 
of microbes [21–23] and human cells [18, 20]. The 
deposition of nanoparticles onto cells is based on  
the relatively short (~5 min) exposure of cells to PAH- 
MNPs dispersed in the appropriate isotonic saline 
media. Surface functionalization of human cells 
imposes several important limitations on the design 
of nanoparticles: (1) MNPs should be stable in 
physiological buffers of relatively high salinity, and 
(2) MNPs must be sterilized prior to deposition onto 
cells. Importantly, nanoparticles should not penetrate 
into nanocoated cells at early stages of functionalization; 
in other words, the nanocoatings should be localized 
exclusively on the outer surfaces of the cellular 
membranes. The uniformity and size distribution of 
PAH-stabilized MNPs was characterized using AFM, 
and a typical AFM image of MNPs is shown in 
Fig. 1(a). Individual nanoparticles in pure water were 
found to be approximately 29 ± 5 nm in size, which 
corresponds well with our previous results [24]. 
Nanoparticles form well-dispersed aggregates, which 
can be visualized using enhanced dark field (EDF) 
microscopy (Fig. 1(b)). Imaging of PAH-MNPs using 
EDF microscopy is an important tool for investigating 
the distribution of PAH-MNPs on cellular membranes, 
and it facilitates the detection of nanoparticles in situ, 
without pre-treatment or fixation of cells. 
Normally, hydrophilic nanoparticles tend to aggregate 
if dispersed in physiological saline solutions [20]. 
Aggregated nanoparticles (with sizes exceeding 200 nm) 
cannot be effectively filtered through 220-nm pore 
filters, thus severely limiting the application of MNPs 
in human cell functionalization. We investigated the 
aggregation of PAH-MNPs in saline buffers by 
automatic titration of nanoparticle suspensions and 
found that PAH-coated nanoparticles were stable 
within the physiological range of salinity, retaining 
their hydrodynamic diameters (~180 nm) and positive 
zeta-potential (+20 mV), as shown in Fig. 1(c). Nano-
particles aggregated (and showed drastically reduced 
zeta-potentials) only at 0.5 M NaCl, which is far above 
the level necessary for biocompatibility (0.15 M). The 
relatively small size of the aggregated MNPs allowed 
successful filtration of the MNPs suspensions using 
0.22-μm filters to maintain sterility, while the positive  
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Figure 1 Characterization of PAH-stabilized MNPs. (a) AFM 
image of PAH-stabilized MNPs; (b) enhanced dark-field optical 
microscopy image of PAH-stabilized MNPs; (c) the stability   
of PAH-stabilized MNPs in increasing NaCl concentrations, as 
determined using simultaneous hydrodynamic diameter and zeta- 
potential measurements. 
zeta-potential of the MNPs promoted their self- 
assembly on the cellular membranes.  
3.2 Human cell surface engineering with PAH- 
stabilized MNPs 
In this study, we used two types of isolated human 
cells (adenocarcinomiс human alveolar basal epithelial 
cells, or A549 cells, and primary skin fibroblasts (HSF)) 
for magnetic surface functionalization with PAH- 
stabilized MNPs. The magnetization procedure is rapid 
and is based on introduction and brief incubation 
(~5 min) of suspended cells into a suspension of MNPs 
(0.05 mg MNPs per 106 cells). An excess volume of 
MNPs was used to ensure the homogenous and uni-
form deposition of MNPs onto cellular membranes. 
Aggregated, positively charged MNPs readily assemble 
on negatively charged human cells, but the overall 
negative charge of cells remains unchanged (Table 1). 
This suggests that magnetic nanoparticles deposited 
at the selected relatively low concentration do not 
completely cover the cells, as shown in our previous 
study of HeLa cells (at higher concentrations of MNPs) 
[18]; instead, they form a rather thin and scattered 
mesoporous coating. To characterize MNPs deposition 
Table 1 Zeta-potential measurements of A549 and HSF cells 
before and after cell surface engineering with PAH-MNPs 
Cells Zeta-potential (intact) Zeta-potential (MNPs-coated) 
A549 –24.5 ± 0.5 mV –23.8 ± 0.7 mV 
HSF –20 ± 0.6 mV –19 ± 0.9 mV 
 
on cells, we applied optical, scanning electron (SEM), 
transmission electron (TEM), and hyperspectral 
microscopy (HM). As previously demonstrated on 
microbial [23, 24] and human cells [18, 20, 25], the 
layers of PAH-stabilized MNPs on cellular membranes 
can clearly be visualized under an optical microscope 
using the bright field imaging mode. Figures 2(a)–2(d) 
shows optical microscopy images of surface-modified 
MNPs-coated A549 and HSF cells, along with their 
uncoated counterparts. The morphology of the magneti-
cally functionalized cells was not affected by the MNPs 
aggregates, which were arranged into a relatively 
thick mesoporous monolayer on the cell membranes. 
SEM images of MNPs-coated cells (Figs. 2(e)–2(h)) also 
confirmed the uniform deposition of MNPs, which 
apparently intercalate and preferentially attach to  
the negatively charged carbohydrate-rich microvilli 
network. Although the density of nanoparticles was 
relatively high, free microvilli can still be clearly seen 
in the SEM images. Moreover, SEM imaging requires 
drying and sputter-coating of cells with a thin con-
ductive layer, inducing closer contact between MNPs 
and microvilli, whereas in native environments the 
microvilli usually protrude through the monolayer of 
MNPs. This was further confirmed using TEM of 
thin-cut resin-embedded cells (Figs. 2(i)–2(l)), demon-
strating the exclusive localization of MNPs on the 
outer surfaces of cellular membranes, where they were 
attached to the microvilli. The extracellular localization 
of PAH-stabilized MNPs increases the biocompatibility 
of this facile magnetization approach, compared with 
conventional magnetization approaches based on 
intracellular labeling [26]. Importantly, the mesoporous 
MNPs-nanoshells are permeable to nutrients and other 
macromolecules, which would facilitate cell growth 
and proliferation. The nanoparticle layer completely 
encircles the cells, and thus can also be utilized to 
attenuate the adhesive properties of MNPs-coated 
cells. 
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Additionally, we investigated PAH-stabilized MNPs- 
coated cells using hyperspectral microscopy (Fig. 3). 
The reflected light spectral response depends on the 
optical properties of the intact and PAH-stabilized 
MNPs-coated cells; magnetized cells are outlined by 
the relatively thick layer of MNPs. A characteristic 
peak at 420 nm was observed for MNPs-coated cells, 
whereas the intact cells did not exhibit clear peaks 
within 420–820 nm. True-color rendered hyperspectral 
images of intact and MNPs-coated HSF cells are shown 
in the insets in Fig. 3; the characteristic brown hue of 
MNPs can clearly be seen on the MNPs-coated cells. 
Similar results were obtained for A549 cells (data not 
shown). 
Intensity-normalized reflected light spectra profiles 
of MNPs-coated cells and intact cells can be applied for 
differentiation of MNPs-coated cells in cell mixtures. 
Using hyperspectral mapping (data not shown), we  
determined that 100% of both A549 and HSF cells 
were coated with MNPs, if coated using the predeter-
mined low-concentration (0.05 mg per 106 cells) MNPs 
suspension in saline buffer. We previously demon-
strated that higher concentrations of MNPs can also 
be applied [18]; however, we believe that the delicate 
procedure of artificial tissue assembly requires appli-
cation of the lowest effective concentration of MNPs 
for functionalization of cells. 
3.3 PAH-stabilized MNPs do not affect the 
physiological properties of magnetized human cells 
Although the magnetic modification of human cells 
has become a routine method in tissue engineering 
research [1, 2, 10], limited data are currently available 
on the effects of MNPs on magnetically modified 
cells. Particularly, magnetization approaches based on 
intracellular introduction of MNPs into the cytoplasm 
 
Figure 2 Bright-field optical microscopy images of intact A549 (a) and HSF (c) cells and MNPs-coated A549 (b) and HSF (d) cells (note 
the characteristic brown color of the cells caused by MNPs deposition); SEM images of intact A549 (e) and HSF (g) cells and MNPs-coated
A549 (f) and HSF (h) cells; TEM images of intact A549 (i) and HSF (k) cells and MNPs-coated A549 (j) and HSF (l) cells. 
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were used to systematically assess the influence of 
MNPs on cellular physiology, although to date only 
limited data has been published, based on either 
viability dyes tests [27, 28] or enzyme activity tests 
[29]. In this study, we thoroughly investigated the 
physiological activity of PAH-stabilized MNPs-coated 
A549 and HSF cells, employing a complex approach 
based on the simultaneous investigation of membrane 
integrity, enzyme activity, and apoptosis induction in 
magnetically modified cells. First, we applied viability 
staining using an ethidium bromide/acridine orange 
dye mixture, which allows viable cells to be distin-
guished from their dead counterparts. Magnetic 
nanoparticles attached to the cellular membranes  
can potentially damage membranes; therefore, it was 
important to demonstrate that membrane integrity is 
preserved in PAH-stabilized MNPs-coated human cells, 
as shown in Figs. 4(a)–4(d). Fluorescence microscopy 
images of intact and MNPs-coated A549 and HSF 
cells demonstrated that the magnetization procedure 
does not significantly reduce the integrity of cellular 
membranes in MNPs-coated cells. 
Next, we investigated whether cell surface fun-
ctionalization with MNPs induces apoptosis in magnetic 
human cells. We employed merocyanine 540 (MC540) 
dye, which adsorbs on the cellular membranes at the 
early stages of apoptosis, along with flow cytometry 
measurements at 12 and 24 h of incubation after 
magnetization. Fluorescein diacetate (FDA) viability 
dye was used to counterstain viable cells. The results 
are shown in Fig. 4(e) and in Table 2. Flow cytometry 
allowed us to simultaneously identify populations  
of cells stained with either dye. Overall, magnetic 
functionalization did not significantly increase the 
number of apoptotic cells in either cell line studied. 
Specifically, in the case of magnetically coated A549 
cells, the largest number of cells observed constituted 
the FDA-positive/merocyanine540-negative (95.5%) 
population, which are viable non-apoptotic cells, 
whereas the number of apoptotic cells was very low 
(3.1%). Similar results were observed for MNPs-coated 
HSF cells. The higher levels of apoptotic HSF cells 
compared with the A549 cells are likely to have been 
caused by the physiological characteristics of cultured 
primary skin fibroblast cells. Notably, after 24 h of 
growth no apoptotic cells retained viability in either 
magnetized or intact A549 cells, whereas in HSF cells 
we observed a minor fraction (~1%) of viable apoptotic 
cells. We also observed a significant increase in necrotic 
cells populations in both intact and magnetized human 
skin fibroblasts, compared with A549 cells. However, 
the absolute numbers of apoptotic and necrotic cells  
 
Figure 3 Reflected light spectra obtained from MNPs-coated and intact HSF cells (typical hyperspectral images of cells are given in insets).
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Figure 4 Fluorescence microscopy images of intact and MNPs-coated A 549 ((a), (c)) and HSF ((b), (d)) cells stained with ethidium 
bromide (red, nuclei of dead cells) and acridin orange (green, cytoplasm of live cells); flow cytometry data (e) demonstrating merocyanine
540 test for apotosis induction. 
Table 2 Flow cytometry data demonstrating the viability of MNPs-functionalized A549 and HSF cells: simultaneous staining with 
FDA (viability) and merocianin (apoptosis) dyes. The data demonstrates the absence of an influence of magnetic functionalization on 
apoptosis induction in A549 cells and weak induction of apoptosis in HSF cells 

























0 h 96% / 91.4% 1.8% / 1% 2.0% / 7% 89.2% / 84.7% 3.9% / 1.7% 6.5% / 9.7% 
12 h 95.7% / 95.1% 0.3% / 0.1% 3.9% / 4.1% 82.9% / 70.5% 2.2% /3.7% 11% / 24.8% 
24 h 97.4% / 95.5% 0 / 0 2.1% / 3.1% 75.1% / 71.3% 1% / 0.65% 21.9% / 22% 
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were very low, indicating that cell surface engineering 
with MNPs is a biocompatible approach, which we 
attribute to the exclusive localization of MNPs on 
outer cellular membranes, whereas the accumulation 
of MNPs in lysosomes leads to prominent toxic effects 
[30]. Our results clearly demonstrate that magnetic 
functionalization with PAH-stabilized MNPs did not 
induce apoptosis in cancerous cells (A549) and caused 
negligible induction of apoptosis in primary (HSF) 
cells. 
To investigate the enzymatic activity of the MNPs- 
coated A549 and HSF cells, we employed a set of 
colorimetric assays, namely the NR uptake test, MTT 
assay, and resazurin assay. These tests demonstrate 
the physiological activity of different enzymatic cellular 
ensembles, and were applied simultaneously to 
thoroughly examine the potential toxic effects of cell 
surface-attached MNPs. Overall, we conclude that 
the enzymatic activity of MNPs-coated cells was not 
affected, which indicates the high biocompatibility  
of cell surface functionalization with MNPs. During 
incubation with cells, resazurin is reduced by 
mitochondrial enzymes, producing the pink pigment 
resorufin. The results of the resazurin reduction test 
(Fig. 5(a)) confirmed that redox enzymatic activity 
was unaffected in MNPs-modified cells. NR is a cationic 
dye that penetrates the cell membrane and accumulates 
in lysosomes, where it binds with anionic sites of  
the lysosomal matrix [31]. The results of the NR test 
(Fig. 5(b)) demonstrate that the lysosomal activity  
of magnetically modified cells was unaffected. Based 
on the preserved functionality of three separate  
intracellular enzyme systems, we conclude that PAH- 
stabilized MNPs do not inhibit the enzymatic activity 
of surface-magnetized cells. The results of the MTT 
assay (Fig. 5(c)) confirm the negligible influence of 
magnetic nanoparticles on the enzymatic activity of 
NAD(P)H-dependent oxidoreductases. We assume 
that the intact membranes, enzyme activity, and low 
levels of apoptosis induction observed in MNPs-coated 
cells indicate that these cells will grow in a manner 
identical to intact A549 and HSF cells. 
Finally, given the possible toxic effects of MNPs on 
the cytoskeleton, we investigated the distribution   
of F-actin in magnetically functionalized A549 cells 
using fluorescent-labeled Alexa Fluor 488® phalloidin 
conjugate and DAPI nuclear stain (Fig. 6). We detected 
no visible changes in F-actin distribution in PAH- 
MNPs-coated cells compared with intact cells. 
3.4 Proliferation of PAH-MNPs-coated cells  
After confirming that the viability and physiologic 
activity of PAH-MNPs surface-engineered human cells 
were not compromised, we focused on investigation of 
the growth of the magnetized cells after attachment 
to a substrate. Both A549 and HSF cells were mag-
netized and cultivated normally, along with intact 
cells. PAH-MNPs-coated cells colonized the substrate 
(culture well bottoms) as well as intact cells; notably, 
distinct halo-like brown aggregates of magnetic nano-
particles could clearly be seen in optical microscopy 
images of the central areas of the cells [20], which is a 
characteristic feature of MNPs-modified cells. After 
examining representative optical microscopy images  
 
Figure 5 Quantitative analysis of enzymatic activity in MNPs-coated cells. MTT assay (c): magnetic functionalisation has a weak 
influence on the activity of mitochondrial dehydrogenases in HSF; Resazurin assay (a): MNPs do not affect mitochondrial enzymes in 
cells; Neutral red test (b): lysozomal activity is preserved in MNPs-coated cells. 
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(data not shown), we found that the characteristic 
morphology of magnetically functionalized cells 
matched that of intact cells. Adhesion of cells to 
substrates is a complex process that occurs as a result 
of close cooperation of cell surface adhesion proteins 
and the cytoskeleton. Adhesion (Fig. 7(a)) starts when 
the initially round suspended cell attaches to the 
substrate, then cell spreading occurs, and finally 
specialized contacts between the cell and the substrate 
are established [32]. As long as surface-functionalization 
of cells with PAH-MNPs does not disrupt the activity of 
enzymes in the cytoplasm, we presume that magnetic 
nanoparticles deposited on cellular membranes do  
 
Figure 6 F-actin distribution in intact (a) and magnetically 
functionalized A549 cells (b); no differences in cytoskeleton 
organization were observed. Alexa Fluor 488® phalloidin 
conjugate and DAPI nuclear stain were applied. 
not induce the inhibition of cytoskeleton dynamic 
activity (such as microtubule synthesis, etc.) as well. 
A more profound effect on cellular adhesion might 
be expected from the interaction of MNPs with cell 
surface adhesion proteins, which might be affected 
by the nanoparticles attached to the cell membranes. 
However, we found that the growth rates of MNPs- 
coated cells were similar to, if not exceeding, those of 
intact cells [20]. As seen in high-resolution SEM and 
TEM images (Figs. 2(e)–2(l)), MNPs intercalate the 
cellular microvilli, but do not completely cover the 
cellular surface, thus allowing direct contact between 
the membrane and the substrate; as a result, cells are 
capable of attaching to and spreading on substrates 
in a normal manner.  
Next, we investigated the distribution of PAH-MNPs 
on cellular membranes after adhesion and spreading 
of cells during 24 h of growth. We employed AFM to 
demonstrate that aggregated MNPs were located 
around cellular nuclei (Fig. 7). The nanoparticles were 
located precisely where the dense brown aggregates 
were detected using optical microscopy (Figs. 2(a)– 
2(d)). 
We also applied TEM imaging of thin-sectioned 
MNPs-coated cells after 24 h of growth to determine 
that MNPs are partially taken up by cells during 
proliferation (Figs. 7(e) and 7(i)), suggesting that 
internalization may also contribute to the distribution 
of MNPs between proliferating cells. Growing and 
dividing cells are expected to gradually shed external 
surface coatings, as known from microbial cells [33]. 
Apart from highly visible aggregated MNPs localized 
on perinuclear areas, we expected to detect isolated 
nanoparticles on distal areas of cells. To investigate 
the distribution of nanoparticles on surface-attached 
cells, we applied dark field microscopy together with 
hyperspectral imaging. Figures 8(a) and 8(b) show 
merged fluorescence (DAPI) and EDF (MNPs) images 
of magnetically functionalized A549 and HSF cells. 
One can see that nanoparticles (bright spots) are located 
not only around nuclei, but are also distributed on 
the cell membranes of distal parts of cells. This effect 
can be better visualized in the hyperspectral images 
(Figs. 8(c) and 8(d)).  
We also applied hyperspectral mapping to distinguish 
aggregated nanoparticles from single nanoparticles, 
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which exhibit different reflected light spectra. The 
results are given in Figs. 8(e) and 8(f); aggregated 
MNPs are shown in red, whereas single MNPs are 
shown as green dots (simulated colors). As seen in 
the images, some of the cells were coated with mostly 
non-aggregated MNPs, while others were densely 
coated with both aggregated and non-aggregated 
nanoparticles. 
These experimental results suggest that human 
cells coated with PAH-MNPs undergo the following 
pathway (as shown in Figs. 7(a)): (1) Cells coated with 
aggregated MNPs attach to the substrate; (2) the 
attached cells spread on the substrate, which initiates 
the elongation of the cells and consequently promotes 
the dissociation of nanoparticle aggregates; and finally 
(3) cells actively divide, sharing MNPs between 
“mother” and “daughter” cells, gradually reducing 
the number of aggregates on the cellular membranes. 
We believe that the nanoparticles are gradually 
removed from the cell surfaces and are likely to be 
accumulated in the extracellular matrix; the fate of 
the MNPs will be the subject of a further study. 
Surface-functionalized cells effectively attach to and 
spread on substrates because the MNPs do not alter 
the functionalities of cell surface adhesion proteins. 
As demonstrated using high-resolution microscopy 
(Fig. 2) and zeta-potential measurements, MNPs 
attached to cell microvilli do not completely cover the  
Figure 7 A sketch demonstrating the adhesion and proliferation of MNPs-coated human cells and MNPs cluster distribution between
“mother” and “daughter” cells (a), AFM images (at increasing magnification) showing the aggregated PAH-MNPs on surface-attached 
A549 (b)–(d) and HSF (f)–(h) cells and TEM images demonstrating the internalisation of MNPs into growing A549 (e) and HSF (i) cells.
 www.theNanoResearch.com∣www.Springer.com/journal/12274 | Nano Research 
2527 Nano Res. 2015, 8(8): 2515–2532 
 
Figure 8 Merged fluorescent (DAPI-stained nuclei) and EDF 
(MNPs) microscopy images of magnetically functionalized A549 
(a) and HSF (b) cells attached to the surface; hyperspectral images 
of MNPs distribution in A549 (c) and HSF (d) and respective 
hyperspectral mapping of MNPs ((e) and (f)), demonstrating the 
distribution of aggregated (red) and isolated (green) MNPs. 
cell surface, as in microbial cells [21], but leave sufficient 
nanoparticle-free areas. The nanoparticle coating is 
labile and can easily be moved and displaced during 
cellular adhesion and division. High adhesion and 
proliferation rates for PAH-MNPs surface-functionalized 
human cells (A549 and HSF) were earlier demonstrated 
by our group, using real-time cell index monitoring [20]. 
The preservation of adhesion behavior in surface- 
modified magnetic human cells makes our approach 
attractive for tissue engineering, especially if com-
pared with intracellular magnetic labeling, which was 
reported to affect cell spreading and hence to reduce 
cell adhesive properties [34, 35]. Overall, the preserved 
viability and adhesive properties of MNPs-coated cells 
encouraged us to apply these cells for fabrication of 
two types of artificial tissue prototypes: layered and 
three-dimensional. 
3.5 Fabrication of layered planar tissue constructs 
and multicellular spheroids using MNPs-functionalized 
cells 
Current tissue engineering techniques based on intra-
cellular magnetization of cells have extensively used 
magnetically labeled cells for fabrication of layered 
structures [3] or multicellular spheroids [36]. We 
employed magnetically functionalized A549 and HSF 
cells for fabrication of artificial lung-mimicking layered 
tissue-like constructs [20]. Magnetic cells were deposited 
layer-wise onto culture wells, starting with HSF (0.3 × 106 
cells per well) and finishing with A549 cells (0.5 × 106 
cells per well). The positioning of the MNPs-coated cells 
was facilitated by 3 mm NdFeB cylindrical magnets 
positioned under the wells. Each layer of MNPs-coated 
cells was incubated for 24 h, then the loosely attached 
cells were washed away. After removing the supporting  
magnets, the resulting multicellular clusters (~100 μm 
thick, round, and 3 mm in diameter) were defoliated 
from the substrates and were imaged using optical 
bright light and dark-field microscopies. The two- 
layered architecture of HSF and A549 cells in the 
clusters is supported by the proliferating viable cells 
(Fig. 9(a)). Notably, the porous morphology of the 
artificial multicellular clusters mimics the morphology 
of normal human lung tissue [20]. Enhanced dark- 
field high-resolution microscopy (Fig. 9(b)) shows the 
brown aggregated MNPs between the tissue-forming 
cells. To investigate the exact distribution of MNPs, 
we employed hyperspectral mapping (Fig. 9(c)), which 
is based on reflected light spectra collected from the 
whole field of view, using a microscope-attached 
spectrometer. As a reference, we used the spectrum 
collected from the MNPs. We found that the MNPs in 
the multicellular clusters were concentrated predo-
minantly in extracellular areas, which indicates that 
the MNPs are gradually removed from the proliferating 
cells. 
Magnetic nanoparticles removed from the cells and 
accumulated in the extracellular matrix can be utilized 
in magnetically facilitated manipulation of the clusters, 
which allows for effective spatial control over the 
positioning of the clusters. 
Finally, to demonstrate the applicability of PAH- 
MNPs-based human cell surface modification for tissue 
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engineering, we fabricated multicellular spheroids based 
on MNPs-coated A549 cells. Multicellular spheroids 
are cultivated as 3D-cell culture models employed in 
cancer research [37–39] and pharmaceutical screening 
[40, 41]; in addition, applications of spheroids as 
building blocks in tissue engineering have been 
envisaged [36, 42–44]. Thus, rendering multicellular 
spheroids with magnetic functionality is deemed 
important for assembly of artificial tissues, and magnetic 
nanoparticles have been introduced into cells prior to 
fabrication of spheroids [9]. Importantly, PAH-stabilized 
MNPs are equally applicable to both primary and 
malignant cells, whereas earlier reports suggest different 
ways to functionalize cancer and normal cells [45, 46]. 
Magnetic functionality in spherical tissue engineering 
blocks is pivotal for the effective positioning and 
retention of spheroids at desired areas during tissue 
build-up. However, the intercellular labeling or intro-
duction of magnetic nanoparticles into the internal 
volume of spheroids imposes certain limitations. Here, 
we utilized a cell surface engineering approach to 
induce magnetic responsiveness into the A549 cell-built 
multicellular spheroids. Spheroid formation followed 
microscopically during their growth, and the results 
are given in Fig. 10. 
The magnetic behavior of MNPs-functionalized 
spheroids is demonstrated in Movie S1 in the Electronic 
Supplementary Material (ESM), in which the spheroids 
are manipulated by a permanent magnet. The mor-
phology of spheroids grown in hanging drops using 
magnetically functionalized cells matched that of 
those fabricated using non-magnetic A549 cells (data 
not shown). We found that the growth rates of magnetic 
and non-magnetic spheroids were similar, suggesting 
that the PAH-stabilized MNPs do not impede the 
growth of cells in 3-D constructs. EDF microscopy 
images (Figs. 10(d) and 10(e)) demonstrate that the 
MNPs are diffusely distributed on the cell membranes 
and inside cells, which corresponds well with the results 
obtained using cells growing on planar substrates. 
The nuclei were counter-stained with DNA-targeting 
DAPI dye, suggesting that the MNPs do not penetrate 
the nuclei, thus reducing the risk of mutations. Notably, 
MNPs-functionalized spheroids could be collected 
from the hanging drops and then placed on cell growth 
substrates, where they eventually spread and colonized 
the substrate (Fig. 10(f); note the remaining MNPs- 
functionalized cell at the center of the spheroid, 
whereas the proliferating cells bear no visible MNPs 
at the membranes). 
The development of MNPs surface-engineered cell- 
based spheroids apparently follows the same pathway 
as the growth of pure spheroids; consequently, the 
fundamental biochemical processes are not disrupted 
by MNPs. We demonstrated previously that enzymatic 
activity in MNPs-coated cells is not affected; attachment 
and proliferation are actually stimulated by MNPs 
[18, 20]. The cytoskeleton plays a pivotal role in major 
cellular processes, and therefore the building and 
functions of the cytoskeleton should not be jeopardized 
by the MNPs. Here, we applied confocal microscopy 
and phalloidin staining (conjugated with Alexa Fluor 
Figure 9 Optical microscopy image of thin sectioned hematoxylin-eosin stained magnetically facilitated multicellular cluster fabricated
using MNPs-functionalized A 549 and HSF cells (a); hyperspectral microscopy image of the multicellular cluster (b); corresponding
hyperspectral map (matching the image in (b)) illustrating the distribution of MNPs (red) in the extracellular areas (c). 
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488 dye) to investigate the possible effects of PAH- 
coated MNPs on the cytoskeleton of A549 cells. As 
shown in the confocal images, actin filaments in MNPs- 
coated cells in the multicellular spheroids were not 
disrupted, indicating normal cytoskeleton formation 
in surface-engineered cells. These results explain the 
successful growth of spheroids transferred onto planar 
adhesive substrates, since cytoskeleton functions are 
crucial during attachment and colonization.  
Finally, to further demonstrate the feasibility of our 
approach, we fabricated hybrid multicellular spheroids 
using two different types of cells: A549 and HeLa 
human cancer cell lines. We used HeLa cells instead 
of HSF cells because of their higher proliferation rate. 
The cells we co-cultured are similar to the single-culture 
spheroids. Prior to assembly, the cells were fluore-
scence-tagged to enable visualization using confocal 
microscopy. As shown in Fig. 10(i), A549 cells (blue) 
and HeLa cells (red) self-assembled into multicellular 
spherical structures, similar to single-culture spheroids. 
4 Conclusion 
We demonstrate here a new way to fabricate magneti-
cally responsive viable human cells, employing cell 
surface engineering with polymer-stabilized magnetic 
nanoparticles. Cationic polyelectrolyte-coated MNPs 
readily and rapidly attached to negatively charged 
cellular membranes, producing a mesoporous magnetic 
film. We characterized the formation of the nanoparticle 
layer and its removal during cell growth using TEM, 
SEM, AFM, and enhanced dark-field imaging. We 
convincingly demonstrate here that PAH-stabilized 
MNPs are highly biocompatible and do not impair 
membrane integrity, enzymatic activity, adhesion, 
proliferation, or cytoskeleton formation, and do not 
 
Figure 10 Generation of magnetic spheroids using MNPs-coated A 549 cells: 24-h (a), 48-h (b) and 7-d (c) spheroids grown in hanging 
drops; EDF image of 7-d spheroid demonstrating the diffused MNPs at the cellular membranes (d) and merged fluorescence (DAPI) and 
EDF image of MNPs inside cells (e); proliferation of spheroid cells after seeding onto an adhesion surface (note the MNPs remaining at 
the centre of the spheroid) (f); F-actin visualization of a magnetic spheroid (g) and proliferated adhesive cells (h) using phalloidin/Alexa 
Fluor 488 staining (note the differences in F-actin distribution in 3D and 2D cell assemblies); multicellular spheroid from A549 (blue)
and HeLa (red) cells labelled with DID and Dil (i). 
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induce apoptosis in either cancer or primary cells. 
Finally, magnetically functionalized cells were employed 
to fabricate viable magnetically responsive planar cell  
sheets and 3D multicellular spheroids. We believe 
that the approach described here will be a potent tool 
in tissue engineering and regenerative medicine. 
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